| Literature DB >> 31404201 |
Abdullah Sulieman Terkawi1,2,3,4, Basil Bakri5, Amena S Alsadek6, Rawaa H Alsibaee7, Esraa M Alasfar8, Amna H Albakour6, Abdulhannan Y Aljouja7, Nour A Alshaikhwais6, Feras A Fares7, Pamela D Flood9, Hussam Jnaid7,10, Amina A Najib6, Diaa A Saloom6, Noran A Zahra6, Khalid A Altirkawi11.
Abstract
OBJECTIVES: Since the uprising in 2011, there have been limited health-care data from inside Syria regarding women's health. This study aimed to provide an updated account of women's health, including pregnancy, perinatal care, childbirth, and other conditions to identify obstacles and challenges to health-care delivery in Northwestern Syria.Entities:
Keywords: Antenatal care; Syria; cesarean delivery; delivery; refugee; women health
Year: 2019 PMID: 31404201 PMCID: PMC6647916 DOI: 10.4103/ajm.AJM_190_18
Source DB: PubMed Journal: Avicenna J Med ISSN: 2231-0770
Figure 1The study center location represented by the (x) sign in the map
Figure 2Overview of patients’ main diagnosis for each encounter. Summary of the general categories of diseases/conditions that affect the patients who visited our center during the study period
Comprehensive summary of the patients’ diagnoses
| Diagnoses | Total (7213 patients) | % | Refugee camp (4148 patients) | % | Residents (3053 patients) | % | |
|---|---|---|---|---|---|---|---|
| Pregnancy | NA | 4936 | 68.43 | 2955 | 71.24 | 1981 | 64.89 |
| Complications following (induced) termination of pregnancy | O04 | 1 | 0.01 | 0 | 0.00 | 1 | 0.03 |
| Complications following ectopic and molar pregnancy | O08 | 1 | 0.01 | 1 | 0.02 | 0 | 0.00 |
| Complications of the puerperium, not elsewhere classified | O90 | 2 | 0.03 | 0 | 0.00 | 2 | 0.07 |
| Ectopic pregnancy | O00 | 4 | 0.06 | 3 | 0.07 | 1 | 0.03 |
| Hemorrhage in early pregnancy | O20 | 28 | 0.39 | 9 | 0.22 | 19 | 0.62 |
| Hydatidiform mole | O01 | 1 | 0.01 | 0 | 0.00 | 1 | 0.03 |
| Other disorders of amniotic fluid and membranes | O41 | 1 | 0.01 | 0 | 0.00 | 1 | 0.03 |
| Miscarriage | 216 | 3.0 | 120 | 2.9 | 96 | 3.14 | |
| Miscarriage, spontaneous | O03 | 196 | 2.7 | 111 | 2.67 | 85 | 2.78 |
| Miscarriage, threatened | O20.0 | 3 | 0.04 | 2 | 0.05 | 1 | 0.03 |
| Complete or unspecified spontaneous miscarriage without complication | O03.9 | 11 | 0.15 | 5 | 0.12 | 6 | 0.20 |
| Incomplete spontaneous miscarriage without complication | O03.4 | 6 | 0.08 | 2 | 0.05 | 4 | 0.13 |
| Menstrual disorders | 1265 | 17.54 | 654 | 15.77 | 611 | 20.01 | |
| Abnormal uterine and vaginal bleeding, unspecified | N93.9 | 58 | 0.80 | 32 | 0.77 | 26 | 0.85 |
| Absent, scanty, and rare menstruation | N91 | 317 | 4.39 | 165 | 3.98 | 152 | 4.98 |
| Amenorrhea, unspecified | N91.2 | 4 | 0.06 | 1 | 0.02 | 3 | 0.10 |
| Antepartum hemorrhage, not elsewhere classified | O46 | 1 | 0.01 | 1 | 0.02 | 0 | 0.00 |
| Dysmenorrhea, unspecified | N94.6 | 4 | 0.06 | 4 | 0.10 | 0 | 0.00 |
| Excessive bleeding in the premenopausal period | N92.4 | 3 | 0.04 | 3 | 0.07 | 0 | 0.00 |
| Excessive, frequent, and irregular menstruation | N92 | 417 | 5.78 | 220 | 5.30 | 197 | 6.45 |
| Irregular menstruation, unspecified | N92.6 | 293 | 4.06 | 144 | 3.47 | 149 | 4.88 |
| Other abnormal uterine and vaginal bleeding | N93 | 159 | 2.20 | 79 | 1.90 | 80 | 2.62 |
| Pain and other condition associated with menstrual cycle | N94 | 3 | 0.04 | 1 | 0.02 | 2 | 0.07 |
| Primary amenorrhea | N91.0 | 5 | 0.07 | 3 | 0.07 | 2 | 0.07 |
| Secondary amenorrhea | N91.1 | 1 | 0.01 | 1 | 0.02 | 0 | 0.00 |
| Infertility | 126 | 1.75 | 73 | 1.76 | 53 | 1.74 | |
| Female infertility, unspecified | N97 | 84 | 1.16 | 47 | 1.13 | 37 | 1.21 |
| Female infertility, primary | N97 | 25 | 0.35 | 17 | 0.41 | 8 | 0.26 |
| Female infertility, secondary | N97 | 17 | 0.24 | 9 | 0.22 | 8 | 0.26 |
| Genital infection | 317 | 4.39 | 145 | 3.50 | 172 | 5.63 | |
| Candidiasis of vulva and vagina | B37.3 | 27 | 0.37 | 10 | 0.24 | 17 | 0.56 |
| Infections of genitourinary tract in pregnancy | O23 | 36 | 0.50 | 15 | 0.36 | 21 | 0.69 |
| Inflammatory disease of cervix uteri | N72 | 2 | 0.03 | 1 | 0.02 | 1 | 0.03 |
| Inflammatory disease of uterus, except cervix | N71 | 1 | 0.01 | 0 | 0.00 | 1 | 0.03 |
| Other inflammation of vagina and vulva | N76 | 251 | 3.48 | 119 | 2.87 | 132 | 4.32 |
| Noninflammatory genital disorders | 407 | 5.64 | 192 | 4.63 | 215 | 7.04 | |
| Other noninflammatory disorders of cervix uteri | N88 | 4 | 0.06 | 4 | 0.10 | 0 | 0.00 |
| Other noninflammatory disorders of uterus, except cervix | N85 | 4 | 0.06 | 4 | 0.10 | 0 | 0.00 |
| Other noninflammatory disorders of vagina | N89 | 387 | 5.37 | 177 | 4.27 | 210 | 6.88 |
| Other noninflammatory disorders of vulva and perineum | N90 | 7 | 0.10 | 4 | 0.10 | 3 | 0.10 |
| Polyp of female genital tract | N84 | 3 | 0.04 | 2 | 0.05 | 1 | 0.03 |
| Vulvovaginal ulceration and inflammation diseases classified elsewhere | N77 | 2 | 0.03 | 1 | 0.02 | 1 | 0.03 |
| Urinary tract infection | 53 | 0.73 | 34 | 0.82 | 19 | 0.62 | |
| Urinary tract infection, site not specified | N39.0 | 53 | 0.73 | 34 | 0.82 | 19 | 0.62 |
| Breast disorders | 99 | 1.37 | 44 | 1.06 | 55 | 1.80 | |
| Hypertrophy of breast | N62 | 1 | 0.01 | 0 | 0.00 | 1 | 0.03 |
| Infect of breast associated with pregnancy, the puerperium, and lactation | O91 | 4 | 0.06 | 4 | 0.10 | 0 | 0.00 |
| Inflammatory disorders of breast | N61 | 50 | 0.69 | 21 | 0.51 | 29 | 0.95 |
| Other disorders of breast/lactation associated with pregnancy and the puerperium | O92 | 7 | 0.10 | 2 | 0.05 | 5 | 0.16 |
| Other disorders of breast | N64 | 28 | 0.39 | 11 | 0.27 | 17 | 0.56 |
| Unspecified lump in breast | N63 | 9 | 0.12 | 6 | 0.14 | 3 | 0.10 |
| Menopausal disorders | 45 | 0.62 | 23 | 0.55 | 22 | 0.72 | |
| Menopausal and other perimenopausal disorders | N95 | 45 | 0.62 | 23 | 0.55 | 22 | 0.72 |
| Ovarian disorders | 112 | 1.55 | 69 | 1.66 | 43 | 1.41 | |
| Other and unspecified ovarian cysts | N83.2 | 109 | 1.51 | 67 | 1.62 | 42 | 1.38 |
| Salpingitis and oophoritis | N70 | 1 | 0.01 | 0 | 0.00 | 1 | 0.03 |
| Noninflammatory disorders of ovary, fallopian and broad ligament | N83 | 2 | 0.03 | 2 | 0.05 | 0 | 0.00 |
| Others | 34 | 0.47 | 18 | 0.43 | 16 | 0.52 | |
| Abdominal and pelvic pain | R10 | 6 | 0.08 | 2 | 0.05 | 4 | 0.13 |
| Abscess of Bartholin’s gland | N75.1 | 1 | 0.01 | 1 | 0.02 | 0 | 0.00 |
| Clitoris hypertrophy | NA | 1 | 0.01 | 0 | 0.00 | 1 | 0.03 |
| Delayed puberty | NA | 3 | 0.04 | 3 | 0.07 | 0 | 0.00 |
| Diseases of Bartholin’s gland | N75 | 1 | 0.01 | 1 | 0.02 | 0 | 0.00 |
| Dyspareunia | N94.1 | 6 | 0.08 | 3 | 0.07 | 3 | 0.10 |
| Ecchymosis on the genital area | NA | 1 | 0.01 | 0 | 0.00 | 1 | 0.03 |
| Female genital prolapse | N81 | 6 | 0.08 | 5 | 0.12 | 1 | 0.03 |
| Female pelvic inflammatory disorders classified elsewhere | N74 | 1 | 0.01 | 0 | 0.00 | 1 | 0.03 |
| Fever of other and unknown origin | R50 | 2 | 0.03 | 1 | 0.02 | 1 | 0.03 |
| Hormonal disturbances | NA | 2 | 0.03 | 0 | 0.00 | 2 | 0.07 |
| Ovulation pain | NA | 1 | 0.01 | 0 | 0.00 | 1 | 0.03 |
| Postcoital and contact bleeding | N93.0 | 2 | 0.03 | 2 | 0.05 | 0 | 0.00 |
| Vaginal injury after intercourse | NA | 1 | 0.01 | 0 | 0.00 | 1 | 0.03 |
Figure 3Percentage of patients who attended antenatal and postnatal care. Data from 730 patients who delivered on October, November, and December 2017. The figure is divided into four sections (A, B, C, and D); from the top (A), the visits in the first trimester, followed by second (B) and third (C) and at the bottom (D) the postnatal visits. The numbers on the Y-axis represent the frequency of visits during each trimester, whereas the numbers on the X-axis represent the percentage of patients who attended each visit. The green color represents all patients and the percentages beside each bar correspond with total patients. The yellow color represents patients on the refugee camp whereas the orange represents patients living in the same town (i.e., residents). Postnatal care visits are included if the patient return to the center 40 days after delivery
Binary logistic regression model to evaluate the effect of different covenants on achieving the FANC visits
| Beta | SE | OR (95% CI) | ||
|---|---|---|---|---|
| Intercept | 10.1 | 1.20 | — | <0.0001 |
| Condition of living | −1.0 | 0.26 | 0.37 (0.21–0.62) | <0.0001 |
| Age | −0.6 | 0.06 | 0.55 (0.49–0.63) | <0.0001 |
| Nulli vs. Multi | 0.10 | 0.31 | 1.11 (0.60–2.0) | 0.733 |
Model statistics: −2 Log likelihood = 371, Cox & Snell R-square = 0.23, Nagelkerke R-square = 0.48 (i.e., 48% of the variance are explained by the predictors in the model), overall model prediction = 90%, model significance (using Omnibus test) = < 0.0001. Beta = beta coefficient for the intercept (constant), CI = confidence interval; SE = standard error around the coefficient, and OR = odd ratio, with its 95% CI.
Figure 4Patients’ selected barriers for ANC visits. The numbers represent percentage indicated. The patient can choose more than one reason. Color-coded box is presented at the right lower corner. The solid color represents all patients, bars with oblique lines represent patients living in the refugee camp, and bars with light dots represent patients’ resident on town
Demographic and clinical characteristics of deliveries
| Cesarean delivery | Vaginal delivery | All deliveries | |
|---|---|---|---|
| Frequency (%) | 600 (30) | 1457 (70) | 2057 |
| Age (years) | |||
| Mean (SD) | 25.6 (6) | 24.4 (6) | 24.8 (6) |
| Median [Min–Max] | 24 [16–45] | 23 [15–44] | 24 [15–45] |
| Gravida | |||
| Mean (SD) | 3.0 (2) | 3.2 (2) | 3.2 (2) |
| Median [Min–Max] | 2 [1–15] | 3 [1–18] | 3 [1–18] |
| Para | |||
| Mean (SD) | 1.7 (2) | 2.0 (2) | 1.9 (2) |
| Median [Min–Max] | 1 [0–10] | 2 [0–11] | 1 [0–11] |
| Gestational age (wk) | |||
| Mean (SD) | 38.1 (1) | 38.4 (1) | 38.3 (1) |
| Median [Min–Max] | 38 [32–42] | 38 [31–42] | 38 [31–42] |
| Term (%) | 487 (81) | 1193 (82) | 1680 (82) |
| Preterm (<37wk) (%) | 32 (5) | 50 (3) | 82 (4) |
| (>40wk) (%) | 21 (3) | 93 (6) | 114 (5) |
| Missing (%) | 60 (10) | 121 (8.3) | 181 (8.8) |
| Condition of living | |||
| Residents (%) | 245 (41) | 547 (37) | 792 (38) |
| Refugee camp (%) | 355 (59) | 910 (62) | 1265 (61) |
Indications for cesarean delivery
| Indications for cesarean delivery | Frequency | Percentage |
|---|---|---|
| Previous cesarean delivery | 288 | 48.57 |
| Prolonged labor or a failure to progress (dystocia) | 97 | 16.36 |
| Fetal distress | 86 | 14.50 |
| Abnormal presentation (breech or transverse positions) | 42 | 7.08 |
| Failed labor induction | 30 | 5.06 |
| Placental problems (placenta previa, placental abruption, or placenta accreta) | 23 | 3.88 |
| Lack of safe place for vaginal labor | 7 | 1.18 |
| Preeclampsia or eclampsia | 4 | 0.67 |
| Bicornuate uterus | 2 | 0.34 |
| Cord prolapse | 1 | 0.17 |
| Small pelvis | 1 | 0.17 |
| Umbilical cord abnormalities | 1 | 0.17 |
| Postdate | 1 | 0.17 |
Figure 5Selected photo from the refugee camp from which our patients came (during winter 2017)